Linezolid

Oct 15, 2019

New Study Reveals Superiority Of Vibativ® Over Vancomycin In Select Patients With Bacterial Pneumonia

Aug 19, 2019

FDA approves new antibiotic to treat community-acquired bacterial pneumonia

Aug 14, 2019

FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis

Aug 14, 2019

FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs

Aug 14, 2019

FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis

Jun 06, 2019

FDA Advisory Committee Votes Favorably on the Question of the Effectiveness and Safety of Pretomanid in Combination with Bedaquiline and Linezolid for Treatment of Highly Drug-Resistant Forms of Tuberculosis

Nov 26, 2018

MicuRx Enrolls First Patient in a Phase 2 Clinical Trial in U.S. for Novel Antibiotic, Contezolid Acefosamil

Nov 19, 2018

Roivant Sciences and iNtRON Bio Sign Licensing Deal for Novel Anti-Superbugs Biologic SAL200

Apr 23, 2018

Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV® (telavancin) at 2018 ECCMID(TM) Conference

Dec 06, 2017

MicuRx Announces Closing of ¥100 Million Funding

Oct 09, 2017

Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV® (telavancin) at IDWeek(TM) 2017